Literature DB >> 8325962

Somatotropic function in short stature: evaluation by integrated auxological and hormonal indices in 214 children. The Italian Collaborative Group of Neuroendocrinology.

F Dammacco1, M F Boghen, F Camanni, M Cappa, C Ferrari, E Ghigo, G Giordano, S Loche, F Minuto, M Mucci.   

Abstract

GH secretion was evaluated in 214 children and adolescents (age, 5-16 yr; 160 males and 54 females) with short stature (height, < or = 5th percentile) by assessing mean spontaneous overnight GH concentration (normal values, > or = 3 and 3.9 micrograms/L for prepubertal and pubertal subjects, respectively) and responsiveness to stimulation with GH-releasing hormone combined with pyridostigmine (normal peak values, > or = 20 micrograms/L). Plasma insulin-like growth factor-I (IGF-I) was also measured. According to their GH secretory status, children were grouped as follows: group I, 154 subjects with normal spontaneous and stimulated GH (43 slow-growing and 111 normally growing); group II, 39 subjects with low spontaneous, but normal stimulated, GH (27 slow-growing and 12 normally growing); group III, 18 slow-growing subjects with low spontaneous and stimulated GH; and group IV, 3 subjects with normal spontaneous, but low stimulated, GH. The following conclusions were drawn. 1) Forty-five slow-growing subjects (21% of the total sample) had GH deficiency; 27 (12.6%) belonged to group II (with a preserved GH pituitary reserve, denoting a hypothalamic dysfunction) and 18 (8.4%) to group III (with a reduced GH pituitary reserve). 2) Forty-three slow-growing children in group I had normal GH secretion but low mean IGF-I, which may indicate nutritional problems or a biologically hypoactive GH molecule. 3) The remaining 111 subjects in group I (52%), with normal growth rate, but low mean parental height, were considered as having familial and/or constitutional short stature. GH responses after pyridostigmine plus GH-releasing hormone were normal in all children with a normal growth rate. These findings show that besides clinical evaluation, the assessment of spontaneous GH secretion, GH pituitary reserve, and IGF-I concentration allows proper pathophysiological characterization of short stature. By this approach, the frequency of GH deficiency in our sample was higher than commonly thought.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325962     DOI: 10.1210/jcem.77.1.8325962

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Growth hormone (GH) response to GH-releasing hormone in short children: lack of correlation with endogenous nocturnal GH secretion.

Authors:  S Seminara; A Filpo; P Piccinini; F La Cauza; M Cappa; A Faedda; S Loche
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

2.  Is the persistence of isolated GH deficiency in adulthood predicted by anatomical hypothalamic-pituitary alterations?

Authors:  S Vannelli; B Stasiowska; J Bellone; G Aimaretti; S Bellone; T Avataneo; S Cirillo; L Benso
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

3.  Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.

Authors:  G Grugni; G Guzzaloni; F Morabito
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

Review 4.  Diagnosis of growth hormone deficiency.

Authors:  F Camanni
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

5.  Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen.

Authors:  G Guzzaloni; G Grugni; F Morabito
Journal:  J Endocrinol Invest       Date:  1999-05       Impact factor: 4.256

6.  Impairment of growth hormone responsiveness to growth hormone releasing hormone and pyridostigmine in patients affected by Prader-Labhardt-Willi syndrome.

Authors:  L Beccaria; F Benzi; A Sanzari; L Bosio; P Brambilla; G Chiumello
Journal:  J Endocrinol Invest       Date:  1996-11       Impact factor: 4.256

7.  Short procedure of GHRH plus arginine test in clinical practice.

Authors:  G Aimaretti; S Bellone; C Baffoni; G Cornel; C Origlia; L Di Vito; S Rovere; E Arvat; F Camanni; E Ghigo
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

8.  Growth hormone response to oral clonidine test in normal and short children.

Authors:  S Loche; M Cappa; E Ghigo; A Faedda; A Lampis; D Carta; C Pintor
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

9.  Short children with familial short stature show enhancement of somatotroph secretion but normal IGF-I levels.

Authors:  S Bellone; G Corneli; J Bellone; C Baffoni; S Rovere; C de Sanctis; G Bona; E Ghigo; G Aimaretti
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 5.467

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.